Literature DB >> 21272945

Reduced thymic output and peripheral naïve CD4 T-cell alterations in primary progressive multiple sclerosis (PPMS).

David G Haegert1, Jessica D Hackenbroch, Danielle Duszczyszyn, Leslie Fitz-Gerald, Evelyn Zastepa, Helen Mason, Yves Lapierre, Jack Antel, Amit Bar-Or.   

Abstract

We compared naïve CD4 and CD8 T-cell homeostasis in primary progressive multiple sclerosis (PPMS), relapsing-remitting MS (RRMS) and controls. Quantitation of signal joint T-cell receptor (TCR) excision circles (sjTRECs) and quantitative estimates of daily thymic export confirm our previous report of reduced thymic output in RRMS and demonstrate reduced thymic output in PPMS. In PPMS, the decreasing % CD31+ naïve CD4 T-cells but constant sjTRECs and constant naïve CD4 T-cell numbers with age, together with increased Bcl-2 expression suggest increased TCR signaling with increased naïve T-cell survival. We conclude PPMS patients have peripheral immune alterations related to reduced thymic output.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21272945     DOI: 10.1016/j.jneuroim.2010.12.007

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  17 in total

1.  Postthymic expansion in human CD4 naive T cells defined by expression of functional high-affinity IL-2 receptors.

Authors:  Marcin L Pekalski; Ricardo C Ferreira; Richard M R Coulson; Antony J Cutler; Hui Guo; Deborah J Smyth; Kate Downes; Calliope A Dendrou; Xaquin Castro Dopico; Laura Esposito; Gillian Coleman; Helen E Stevens; Sarah Nutland; Neil M Walker; Catherine Guy; David B Dunger; Chris Wallace; Timothy I M Tree; John A Todd; Linda S Wicker
Journal:  J Immunol       Date:  2013-02-15       Impact factor: 5.422

2.  Multiple sclerosis: a disorder of altered T-cell homeostasis.

Authors:  David G Haegert
Journal:  Mult Scler Int       Date:  2011-09-15

Review 3.  Self-tolerance in multiple sclerosis.

Authors:  R E Gonsette
Journal:  Acta Neurol Belg       Date:  2012-03-24       Impact factor: 2.396

4.  Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.

Authors:  Michael P Pender; Peter A Csurhes; Casey Mm Pfluger; Scott R Burrows
Journal:  Mult Scler       Date:  2014-05-19       Impact factor: 6.312

Review 5.  Immunology and oxidative stress in multiple sclerosis: clinical and basic approach.

Authors:  Genaro G Ortiz; Fermín P Pacheco-Moisés; Oscar K Bitzer-Quintero; Ana C Ramírez-Anguiano; Luis J Flores-Alvarado; Viridiana Ramírez-Ramírez; Miguel A Macias-Islas; Erandis D Torres-Sánchez
Journal:  Clin Dev Immunol       Date:  2013-09-24

6.  Naive CD4 T-cell activation identifies MS patients having rapid transition to progressive MS.

Authors:  Evelyn Zastepa; Leslie Fitz-Gerald; Michael Hallett; Jack Antel; Amit Bar-Or; Sergio Baranzini; Yves Lapierre; David G Haegert
Journal:  Neurology       Date:  2014-01-22       Impact factor: 9.910

7.  Systemic toxoplasma infection triggers a long-term defect in the generation and function of naive T lymphocytes.

Authors:  David G Kugler; Francis A Flomerfelt; Diego L Costa; Karen Laky; Olena Kamenyeva; Paul R Mittelstadt; Ronald E Gress; Stephan P Rosshart; Barbara Rehermann; Jonathan D Ashwell; Alan Sher; Dragana Jankovic
Journal:  J Exp Med       Date:  2016-11-14       Impact factor: 14.307

Review 8.  Regulatory T cells in multiple sclerosis and myasthenia gravis.

Authors:  K M Danikowski; S Jayaraman; B S Prabhakar
Journal:  J Neuroinflammation       Date:  2017-06-09       Impact factor: 8.322

9.  Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression.

Authors:  Jeppe Romme Christensen; Lars Börnsen; Rikke Ratzer; Fredrik Piehl; Mohsen Khademi; Tomas Olsson; Per Soelberg Sørensen; Finn Sellebjerg
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

10.  Strain differences in thymic atrophy in rats immunized for EAE correlate with the clinical outcome of immunization.

Authors:  Mirjana Nacka-Aleksić; Marija Stojanović; Ivan Pilipović; Zorica Stojić-Vukanić; Duško Kosec; Gordana Leposavić
Journal:  PLoS One       Date:  2018-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.